Modeling Cancer in Microfluidic Chips
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 30029
Special Issue Editors
Interests: biomedical engineering; organs-on-chips; immunity; lymphatics; cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
Tumors are complex three-dimensional (3D) tissues that establish a dynamic cross-talk between multiple cell types (cancer cells, various stromal cells (e.g., cancer-associated fibroblasts), various types of immune cells, and vascular cells) and the surrounding matrix through complex chemical signaling. Conventional 2D or 3D culture systems, although they have the ability to conserve at least some of the acquired phenotypes, cannot imitate the cell–cell interactions and tissue-level functions, and thus fail to recreate the dynamics of the tumor niche. Cancer-on-chip systems, which are microfluidic devices, aim to recapitulate relevant features of the tumor physiology and have emerged as powerful tools in cancer research. Cancer-on-a-chip models add another dimension of physiological mimicry by allowing a perfusable system that can be integrated with vascular or lymphatic networks. In this Issue, Cancers is launching a Special Collection that highlights the contribution of on-chip cancer models for better understating human cancers and studying drugs. The Special issue will consider articles from the full breadth of research in the field: from original research papers to reviews and methods papers. Areas of interest include, but are not limited to:
- Modeling cancer diseases using “organs-on-chips” for drug discovery;
- Orthotopic cancer organ chips;
- Application of on-chip cancer models using organoids and spheroids in drug discovery, screening, and delivery;
- Cancer-on-a-chip models to share an interface between cancerous and normal microtissues for studying tumor niches;
- Cancer-on-a-chip models for studying the tumor-associated immunosuppressive microenvironment;
- Cancer-on-a-chip models for studying neovascularization;
- Cancer-on-a-chip models for studying metastatic dissemination;
- Cancer-on-a-chip models for developing personalized medicine;
- Cancer-on-a-chip models for modelling responses to drug therapies.
Dr. Esak Lee
Dr. Taslim Ahmed Al-Hilal
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.